PMID: 41453515 The shared pattern is important: in nondiabetic weight-loss populations, GLP-1 receptor agonist exposure was associated with fewer nonexudative AMD diagnoses
However, he emphasised that the current evidence is early and observational, and there is no national or international guidance requiring any change to how these medications are managed before scans
According to the literature, this single 15-amino-acid peptide heals tendons, repairs muscles, protects the gut, fixes the liver, recovers spinal cord injuries, treats retinal ischemia, counteracts drug toxicity, and regulates neurotransmitters
Trends in Endocrinology & Metabolism
Clinical evidence: The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program is the largest body of evidence supporting any weight loss medication